Are symptomatic patients appropriate candidates for carotid artery stenting? No (at least not at present)
Kosmas I Paraskevas1, Dimitri P Mikhailidis, Frank J Veith
1Department of Vascular Surgery, Red Cross Hospital, Athens, Greece.
Insights
Most symptomatic patients should avoid carotid artery stenting (CAS) due to higher risks and costs compared to carotid endarterectomy (CEA). CEA offers better outcomes and is more cost-effective for these individuals currently.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Health Economics
Background:
- Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are procedures to prevent stroke in symptomatic patients.
- The comparative effectiveness and cost-efficiency of CAS versus CEA remain critical considerations in clinical decision-making.
Purpose of the Study:
- To evaluate the current appropriateness of carotid artery stenting (CAS) for symptomatic patients.
- To compare the risks, recurrence rates, and costs associated with CAS versus carotid endarterectomy (CEA).
Main Methods:
- Review of existing clinical data and cost-effectiveness analyses comparing CAS and CEA in symptomatic patients.
- Analysis of stroke rates, recurrent stenosis rates, and economic factors for both procedures.
Main Results:
- Carotid artery stenting (CAS) is associated with higher rates of stroke and recurrent stenosis compared to carotid endarterectomy (CEA) in symptomatic patients.
- CAS is significantly more expensive than CEA.
- Current evidence suggests CEA is a superior option for most symptomatic individuals.
Conclusions:
- Carotid artery stenting (CAS) is not currently recommended for the majority of symptomatic patients.
- Carotid endarterectomy (CEA) remains the preferred, safer, and more cost-effective intervention for these patients at present.
Abstract:
Most symptomatic patients should not be candidates for carotid artery stenting (CAS); at least not at present. In these patients, CAS is associated with higher stroke, as well as recurrent stenosis rates compared with carotid endarterectomy (CEA). Furthermore, CAS is considerably more expensive than CEA. These facts raise the question, why perform CAS in symptomatic patients when you have CEA, which is associated with lower stroke and recurrent stenosis rates, and is also a more cost-effective option. This article supports the theory that currently most symptomatic patients are not appropriate candidates for CAS.
Related Concept Videos
Angina II: Classification
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
